JGEP:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF GBP Hedged Acc (GBX)

ETF | Others |

Last Closing

USD 3741.5

Change

-18.00 (-0.48)%

Market Cap

USD 0.27B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-4.98 (-3.65%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.03 (-0.18%)

USD 581.04B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.07 (-0.41%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.15 (-0.24%)

USD 266.08B
0QZO:LSE 0QZO

-0.90 (-0.83%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.12 (-0.42%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

-0.48 (-0.31%)

USD 202.26B
0R24:LSE Intel Corp.

-0.49 (-2.54%)

USD 196.14B

ETFs Containing JGEP:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.76% 30% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.76% 30% F 37% F
Trailing 12 Months  
Capital Gain 18.86% 78% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.86% 77% C+ 76% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.05% 72% C 74% C
Dividend Return 13.05% 71% C- 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.77% 60% D- 76% C+
Risk Adjusted Return 110.83% 95% A 97% N/A
Market Capitalization 0.27B 65% D 37% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike